Hint mode is switched on Switch off
For swift navigation between sections

HCW Biologics

PDF download

Choose all Reset all
Download Cancel
Organization name
HCW Biologics Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

HCW Biologics Inc is a developer of immunotherapies intended to offer treatments of cancer and aging-associated pathologies. The company's therapies are aimed at lengthening healthspan by focusing on the senescent cells in diseases such as cancer and other aging-associated pathologies, enabling patients to access treatments that can tackle cancer and other diseases associated with aging.

Awards

News

24/06/2026 HCW Biologics: Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Regulation Fd Disclosure, Financial Statements And Exhibits
15/06/2026 HCW Biologics: Submission Of Matters To A Vote Of Security Holders
21/05/2026 HCW Biologics: Termination Of A Material Definitive Agreement, Financial Statements And Exhibits
15/05/2026 HCW Biologics (HCWB) Surges on Q1 2026 EPS Beat & Revenue Jump
15/04/2026 HCW Biologics: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001828673
  • EIN
    82-5024477
Registration is required to get access.